TickerGuard
Buy Day today: Poor (44) Weak market breadth · today: Core PCE (August) ≈
CABA

Cabaletta Bio Inc

Healthcare · Biotechnology

2.20$ -11.2% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Cash Flow

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Cash Flow CABA
Line item 2017 2018 2019 2020 2021 2022 2023 2024 2025
– – – -267,700,000,000.0% – – – – –
– – – 3,540,000,000.0% – – – – –
– – – 43,880,000,000.0% – – – – –
– – – 45,070,000,000.0% – – – – –
– – – 17,080,000,000.0% – – – – –
– – – 6,350,000,000.0% – – – – –
– – – -79,810,000,000.0% – – – – –
– – – -1,920,000,000.0% – – – – –
– – – -240,000,000.0% – – – – –
– – – -347,750,000,000.0% – – – – –
– – – -274,050,000,000.0% – – – – –

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?